Genmab A/S
CSE:GMAB
Genmab A/S
CSE:GMAB
Price:
1 963 DKK
-0.13%
Updated:
May 2, 2024
Genmab A/S
Cash from Investing Activities
|
Genmab A/S
Cash from Investing Activities Peer Comparison
Comparables:
ZEAL
ASND
B
BAVA
BIOPOR
SANION
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Genmab A/S
CSE:GMAB
|
Cash from Investing Activities
-kr1.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Cash from Investing Activities
-kr1.1B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Cash from Investing Activities
€286.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Cash from Investing Activities
-kr945.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-20%
|
|
|
Bioporto A/S
CSE:BIOPOR
|
Cash from Investing Activities
-kr277k
|
CAGR 3-Years
43%
|
CAGR 5-Years
29%
|
CAGR 10-Years
-25%
|
|
|
Saniona AB
STO:SANION
|
Cash from Investing Activities
-kr129k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Genmab A/S's Cash from Investing Activities?
Cash from Investing Activities
-1.3B
DKK
-1.3B
DKK
Based on the financial report for Dec 31, 2023, Genmab A/S's Cash from Investing Activities amounts to -1.3B DKK.
What is Genmab A/S's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
6%
6%
Over the last year, the Cash from Investing Activities growth was 54%. The average annual Cash from Investing Activities growth rates for Genmab A/S have been 18% over the past three years , 6% over the past five years .
You don't have any saved screeners yet
